NBAS mutations cause acute liver failure: when acetaminophen is not a culprit.
Open Access
- 25 September 2017
- journal article
- case report
- Published by Springer Science and Business Media LLC in Italian Journal of Pediatrics
- Vol. 43 (1), 88
- https://doi.org/10.1186/s13052-017-0406-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Intensive Care Management of Pediatric Acute Liver FailureJournal of Pediatric Gastroenterology and Nutrition, 2017
- Liver transplantation for drug-induced acute liver failure.2017
- Acute Liver Failure Meets SOPH Syndrome: A Case Report on an Intermediate PhenotypePEDIATRICS, 2017
- N‐acetylcysteine for non‐paracetamol drug‐induced liver injury: a systematic reviewBritish Journal of Clinical Pharmacology, 2016
- Clinical Course among Cases of Acute Liver Failure of Indeterminate DiagnosisThe Journal of Pediatrics, 2016
- Neuroblastoma Amplified Sequence (NBAS) mutation in recurrent acute liver failure: Confirmatory report in a sibship with very early onset, osteoporosis and developmental delayEuropean Journal of Medical Genetics, 2015
- Efficacy and safety of acetylcysteine in “non-acetaminophen” acute liver failure: A meta-analysis of prospective clinical trialsClinics and Research in Hepatology and Gastroenterology, 2015
- Toxicity From Repeated Doses of Acetaminophen in ChildrenClinical Journal of Sport Medicine, 2014
- Chronic Acetaminophen Exposure in Pediatric Acute Liver FailurePEDIATRICS, 2013
- An update of N-acetylcysteine treatment for acute acetaminophen toxicity in childrenCurrent Opinion in Pediatrics, 2005